Axsome Therapeutics, Inc.: Cantor Fitzgerald Maintains Buy Recommendation







Marketzone with MT Newswires 2022

All the news about AXSOME THERAPEUTICS, INC.

Analyst Recommendations for AXSOME THERAPEUTICS, INC.

2022 turnover 52.6M
–
52.4M
2022 net result -173M
–
-172M
trso. net 2022 131M
–
131M
PER 2022-9.68x
2022 return–
Capitalization 1,710M
1,710M
1,703M
VE / CA 202230.0x
VE / CA 20237.12x
Number of employees198
Floating80.1%

Chart AXSOME THERAPEUTICS, INC.


Hard :

Period:




Axsome Therapeutics, Inc.: Axsome Therapeutics, Inc. Technical Analysis Chart | Market area

Trends Technical Analysis AXSOME THERAPEUTICS, INC.

Short termMiddle termLong term
Trendsbullishbullishbullish

Evolution of the Income Statement

Sale

Purchase

Average recommendationTO BUY
Number of Analysts13
Last Closing Price$42.43
Average price target$87.90
Deviation / Average Target107%

Officers and Directors




Source link -88